知名学者引用


        除了所发表论文的被引用频次、期刊质量能够彰显学者的学术影响力以外,被知名学者引用也是一项学术评价的重要指标。
        当前全球学者库认定的知名学者包括:诺贝尔奖、菲尔兹奖、图灵奖等奖项获得者,多个国家的院士,全球学者库“2023全球学者学术影响力排行版”入榜的前10万学者等。

Zhang, Shanyuan 北京大学被知名学者引用:117人次(黄金会员以上可以申请导出本人论文被全部知名学者引用的数据)

1. Bert W. O'Malley 美国 Baylor College of Medicine 1993美国医学院院士;1992美国科学院院士 Drug-induced PD-L1 expression and cell stress response in breast cancer cells can be balanced by dru..

2. 王俊 中国 北京大学 中国工程院院士 Primary tumour resection in non-small-cell lung cancer patients with ipsilateral pleural disseminati..

3. 曾益新 中国 国家卫生健康委员会 中国科学院院士 Changes in Expression of Multiple Checkpoint Molecules and Infiltration of Tumor Immune Cells after ..

4. Ken,Shirabe 日本 Gunma University Prognostic value of a modified-immune scoring system in patients with pathological T4 colorectal can..

5. Marcello,Tiseo 意大利 University of Hospital PARMA Redetermination of PD-L1 expression after chemio-radiation in locally advanced PDL1 negative NSCLC p..

6. Nagini, Siddavaram 印度 Annamalai University Crosstalk between PD-L1 and Jak2-Stat3/MAPK-AP1 signaling promotes oral cancer progression, invasion..

7. Nasser K,Altorki 美国 New York Presbyterian Hospital Regulation of PD-L1 Trafficking from Synthesis to Degradation

8. Timothy E,McGraw 美国 Weill Cornell Medical College Regulation of PD-L1 Trafficking from Synthesis to Degradation

9. Nasser K,Altorki 美国 New York Presbyterian Hospital Proximity proteome mapping reveals PD-L1-dependent pathways disrupted by anti-PD-L1 antibody specifi..

10. Timothy E,McGraw 美国 Weill Cornell Medical College Proximity proteome mapping reveals PD-L1-dependent pathways disrupted by anti-PD-L1 antibody specifi..

11. 任秀宝 中国 天津医科大学 主任医师 Effect of Chemotherapeutics on In Vitro Immune Checkpoint Expression in Non-Small Cell Lung Cancer

12. Zatollah,Asemi 伊朗 Kashan University Medicine Science CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer

13. Bahman,Yousefi 伊朗 Tabriz University of Medical Science CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer

14. Adrian F,Ochsenbein 瑞士 University of Bern The effect of neoadjuvant therapy on PD-L1 expression and CD8+lymphocyte density in non-small cell l..

15. Chen, Miao-Fen 中国 长庚大学 Adjuvant Chemoradiotherapy Associated with Improved Overall Survival in Resected Esophageal Squamous..

16. 孙毅 中国 浙江大学 PD-L1 induction via the MEK-JNK-AP1 axis by a neddylation inhibitor promotes cancer-associated immun..

17. 黃志扬 中国 台湾中国医药大学 Dual inhibition of TGF beta signaling and CSF1/CSF1R reprograms tumor-infiltrating macrophages and i..

18. K.S. Clifford,Chao 中国 台湾中国医药大学 Dual inhibition of TGF beta signaling and CSF1/CSF1R reprograms tumor-infiltrating macrophages and i..

19. 胡夕春 中国 复旦大学上海医学院 Temporal Heterogeneity of HER2 Expression and Spatial Heterogeneity of F-18-FDG Uptake Predicts Trea..

20. Massimo,Dominici 意大利 University of Modena & Reggio Emilia Cancer Stem Cells (CSCs), Circulating Tumor Cells (CTCs) and Their Interplay with Cancer Associated ..

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3